Flamholc L, Haidl S, Westin E, Borgdalen L, Prellner T
Dept. of Infectious Diseases, Malmö General Hospital, University of Lund, Sweden.
Infection. 1992 Nov-Dec;20(6):309-12. doi: 10.1007/BF01710670.
In a prospective trial of aerosolized pentamidine as secondary prophylaxis for Pneumocystis carinii pneumonia (PCP) 18 patients received 400 mg once weekly for a mean period of 15.5 months. Pentamidine aerosol was administered with an MA2 jet nebulizer. No PCP relapses were observed and no serious side effects occurred.
在一项关于雾化喷他脒作为卡氏肺孢子虫肺炎(PCP)二级预防措施的前瞻性试验中,18名患者每周接受一次400毫克喷他脒治疗,平均治疗期为15.5个月。喷他脒气雾剂通过MA2喷射雾化器给药。未观察到PCP复发,也未出现严重副作用。